This panel was chosen because some analytes have been reported to be related to ALS (e.g., YKL-40 [22], CHIT1 [23], MCP-1 [24]) and we have previously used this panel for CSF-based biomarker discovery for ALS [25]. This evidence concerns the gene CHI3L1 and amyotrophic lateral sclerosis.